The Evidence-Based Reimbursement Summit is comprised of back-to-back conferences, Part I – Generating Evidence for Reimbursement Decisions: Therapeutics and Part II – Generating Evidence for Reimbursement Decisions: Diagnostics.
The event will be held from October 21 to 23, 2013 at the Hyatt Regency Bethesda in Bethesda, Md.
The second annual Generating Evidence for Reimbursement Decisions: Diagnostics conference aims to convene key players in the field of evidence-based reimbursement in diagnostics.
Featured presentations include:
Evaluating Novel Diagnostics for Reimbursement
Elaine K. Jeter, MD
J1 MolDx Medical Director, Palmetto GBA
CPT Codes for Multigene Testing Using Next-Generation Sequencing: Opportunities and Challenges Ahead
Roger Klein, MD, JD, Department of Molecular Pathology, Cleveland Clinic Foundation
Oncology Drug Development – Meeting The Evidentiary Needs of Various Stakeholders
Jerry Conway, vice president, reimbursement and payer strategy, Foundation Medicine Inc
Click here to view the agenda pdf.
[Source: Cambridge Healthtech Institute]
